SFRP1 exerts as a tumor suppressor by repressing Wnt/β-catenin pathway in multiple tumors, such as breast cancer [49], head and neck squamous cell carcinoma and skin squamous cell carcinoma [50], and ovarian cancer [51]. Here, SFRP1 is linked to neoplasm.